✦ LIBER ✦

Prospective evaluation of sexual function in patients receiving cryosurgery as a primary radical treatment for localized prostate cancer

✍ Scribed by Susan Asterling; Damian R. Greene

Book ID: 109054374
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 158 KB
Volume: 103
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2008.08042.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective assessment of voiding and se

Prospective assessment of voiding and sexual function after treatment for localized prostate carcinoma : Comparison of radical prostatectomy to hormonobrachytherapy with and without external beam radiotherapy

✍ Brant R. Fulmer; Eric A. Bissonette; Gina R. Petroni; Dan Theodorescu 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 2 views

Survival outcomes in men receiving andro

Survival outcomes in men receiving androgen-deprivation therapy as primary or salvage treatment for localized or advanced prostate cancer: 20-year single-centre experience

✍ Christopher J. DiBlasio; John B. Malcolm; Jessica Hammett; Jim Y. Wan; Michael A 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB

Intraoperative radiotherapy during radic

Intraoperative radiotherapy during radical prostatectomy for intermediate-risk to locally advanced prostate cancer: treatment technique and evaluation of perioperative and functional outcome vs standard radical prostatectomy, in a matched-pair analysis

✍ Bernardo Rocco; Barbara A. Jereczek-Fossa; Deliu-Victor Matei; Fabrizio Verweij; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB

Estimating survival gain for economic ev

Estimating survival gain for economic evaluations with survival time as principal endpoint: A cost-effectiveness analysis of adding early hormonal therapy to radiotherapy in patients with locally advanced prostate cancer

✍ N. Neymark; I. Adriaenssen; T. Gorlia; S. Caleo; M. Bolla 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB 👁 1 views

## Abstract The problem of estimating expected outcomes for the economic evaluation of treatments for which the outcome of principal interest is (quality adjusted) survival time has so far not received sufficient attention in the literature. The best estimate of expected survival is mean survival t